Skip to content


MAP, a combination consisting of the chemotherapy drugs methotrexate, doxorubicin, and cisplatin, is employed for treating osteosarcoma, a form of primary bone cancer. Understanding the intricacies of this treatment, including its administration, potential side effects, and precautionary measures, is essential for patients to actively engage in their care and enhance treatment outcomes. Download the MAP protocol for further information.